AMGAX | PMBMX | AMGAX / PMBMX | |
Total Expense Ratio | 1.27 | 1.14 | 111% |
Annual Report Gross Expense Ratio | 1.27 | 1.14 | 111% |
Fund Existence | 29 years | 25 years | - |
Gain YTD | 8.783 | 6.854 | 128% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 262M | 32.3B | 1% |
Annual Yield % from dividends | 0.00 | 0.02 | - |
Returns for 1 year | 20.29 | 14.80 | 137% |
Returns for 3 years | 58.48 | 50.19 | 117% |
Returns for 5 years | 2.85 | 55.71 | 5% |
Returns for 10 years | 47.19 | 94.74 | 50% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MUOSX | 31.81 | 0.31 | +0.98% |
Morgan Stanley Instl US Core R6 | |||
GSSQX | 65.60 | 0.56 | +0.86% |
Goldman Sachs US Equity Insights A | |||
RMFEX | 59.82 | 0.38 | +0.64% |
American Funds American Mutual R4 | |||
RCGHX | 15.42 | 0.04 | +0.26% |
Virtus KAR Health Sciences C | |||
MLPRX | 4.74 | N/A | -0.05% |
Invesco SteelPath MLP Income C |